Classification-based therapy no better for back pain

February 21, 2012
Classification-Based therapy no better for back pain
Treatment of patients with lower back pain using a classification-based physical therapy approach shows no statistically significant superiority to treatment with usual physical therapy care, according to a study published online Feb. 13 in Spine.

(HealthDay) -- Treatment of patients with lower back pain (LBP) using a classification-based physical therapy approach shows no statistically significant superiority to treatment with usual physical therapy care, according to a study published online Feb. 13 in Spine.

Adri T. Apeldoorn, of the VU University Medical Center in Amsterdam, and colleagues compared outcomes of classification-based physical therapy treatment to those of usual physical therapy care for 156 patients with sub-acute or chronic LBP. All participants were classified by research using a modified version of Delitto's classification-based system, and were then randomly allocated to receive Delitto's classification-based treatment approach (74 patients) or usual physical therapy (82 patients). Patients underwent follow-up at eight, 26, and 52 weeks.

The researchers found that there were no statistically significant differences between the two groups for outcomes at any time points. After eight weeks, patients in the classification-based group had increased global perceived effect scores (adjusted odds ratio, 1.01; 95 percent confidence interval, 0.31 to 3.28). They also had higher adjusted Oswestry Disability Index scores and (numerical rating scale) scores (0.48 and 0.49 points, respectively). None of the differences were found to be statistically significant.

"The classification-based system as used in this study was not effective for improving physical therapy care outcomes in a population of patients with sub-acute and chronic LBP," the authors write.

Explore further: New therapy may help people with unexplained symptoms of pain, weakness and fatigue

More information: Abstract
Full Text (subscription or payment may be required

Related Stories

New therapy may help people with unexplained symptoms of pain, weakness and fatigue

July 27, 2011
A new type of therapy may help people with symptoms such as pain, weakness, or dizziness that can't be explained by an underlying disease, according to a study published in the July 27, 2011, online issue of Neurology, the ...

Recommended for you

Research examines lung cell turnover as risk factor and target for treatment of influenza pneumonia

July 24, 2017
Influenza is a recurring global health threat that, according to the World Health Organization, is responsible for as many as 500,000 deaths every year, most due to influenza pneumonia, or viral pneumonia. Infection with ...

Scientists propose novel therapy to lessen risk of obesity-linked disease

July 24, 2017
With obesity related illnesses a global pandemic, researchers propose in the Journal of Clinical Investigation using a blood thinner to target molecular drivers of chronic metabolic inflammation in people eating high-fat ...

Raccoon roundworm—a hidden human parasite?

July 24, 2017
The raccoon that topples your trashcan and pillages your garden may leave more than just a mess. More likely than not, it also contaminates your yard with parasites—most notably, raccoon roundworms (Baylisascaris procyonis).

Google searches can be used to track dengue in underdeveloped countries

July 20, 2017
An analytical tool that combines Google search data with government-provided clinical data can quickly and accurately track dengue fever in less-developed countries, according to new research published in PLOS Computational ...

MRSA emerged years before methicillin was even discovered

July 19, 2017
Methicillin resistant Staphylococcus aureus (MRSA) emerged long before the introduction of the antibiotic methicillin into clinical practice, according to a study published in the open access journal Genome Biology. It was ...

New test distinguishes Zika from similar viral infections

July 18, 2017
A new test is the best-to-date in differentiating Zika virus infections from infections caused by similar viruses. The antibody-based assay, developed by researchers at UC Berkeley and Humabs BioMed, a private biotechnology ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.